The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system …

AB Porcaro, A Bianchi, A Panunzio… - Therapeutic …, 2024‏ - journals.sagepub.com
Background: Treatment outcomes in intermediate-risk prostate cancer (PCa) may be
impaired by adverse pathology misclassification including tumor upgrading and upstaging …

Innovations in Metal-Based Nanomedicines to Interfere with the Signaling Communications of Prostate Cancer

M Habeeb, KL Deepthi, HT Vengateswaran, S Arsey… - BioNanoScience, 2025‏ - Springer
Prostate cancer is the second most lethal malignancy in males noticed worldwide. The early
stage symptoms of prostate cancer are often unnoticed, which results in delayed diagnosis …